CD8A and COVID-19: The CD8+ T cell response towards the HLA-A*02:01 restricted YLQ peptide has previously been reported [10,11,16,17,18]; however, data regarding the level of polyfunctionality associated with the CD8+ T cell response has been limited in COVID-19 recovered donors.